Linden Thomas Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63M | Buy |
8,161
+428
| +6% | +$191K | 0.4% | 66 |
|
|
2025
Q1 | $3.75M | Buy |
7,733
+292
| +4% | +$142K | 0.49% | 41 |
|
|
2024
Q4 | $3M | Buy |
7,441
+644
| +9% | +$259K | 0.38% | 63 |
|
|
2024
Q3 | $3.16M | Buy |
6,797
+613
| +10% | +$285K | 0.43% | 45 |
|
|
2024
Q2 | $2.9M | Sell |
6,184
-139
| -2% | -$65.2K | 0.45% | 43 |
|
|
2024
Q1 | $2.64M | Buy |
6,323
+323
| +5% | +$135K | 0.42% | 42 |
|
|
2023
Q4 | $2.44M | Buy |
6,000
+541
| +10% | +$220K | 0.46% | 42 |
|
|
2023
Q3 | $1.9M | Sell |
5,459
-7,135
| -57% | -$2.48M | 0.42% | 49 |
|
|
2023
Q2 | $4.43M | Buy |
12,594
+626
| +5% | +$220K | 0.98% | 6 |
|
|
2023
Q1 | $3.77M | Buy |
11,968
+482
| +4% | +$152K | 0.94% | 11 |
|
|
2022
Q4 | $3.32M | Buy |
+11,486
| New | +$3.32M | 0.93% | 7 |
|